European Journal of Nutrition

, Volume 51, Issue 5, pp 615–622 | Cite as

Serum and lipoprotein sitostanol and non-cholesterol sterols after an acute dose of plant stanol ester on its long-term consumption

  • H. GyllingEmail author
  • M. Hallikainen
  • P. Simonen
  • H. E. Miettinen
  • M. J. Nissinen
  • T. A. Miettinen
Original Contribution



Chronic inhibition of cholesterol absorption with large doses of plant stanol esters (staest) alters profoundly cholesterol metabolism, but it is unknown how an acute inhibition with a large staest dose alters the postprandial serum and lipoprotein cholesterol precursor, plant sterol, and sitostanol contents.


Hypercholesterolemic subjects, randomly and double-blind divided into control (n = 18) and intervention groups (n = 20), consumed experimental diet without and with staest (plant stanols 8.8 g/day) for 10 weeks. Next morning after a fasting blood sample (0 h), the subjects had a breakfast without or with staest (4.5 g of plant stanols). Blood sampling was repeated 4 h later. Lipoproteins were separated with ultracentrifugation, and sterols were measured with gas–liquid chromatography.


In 0-h chylomicrons and VLDL, plant sterols were lower in staest than in controls. Postprandially, cholestenol (cholesterol synthesis marker) was reduced in chylomicrons in staest compared with controls (−0.13 ± 0.04 μg/dL vs. 0.01 ± 0.08 μg/dL, P < 0.05). Staest decreased postprandially avenasterol in chylomicrons (P < 0.05 from 0 h). Sitostanol was high at 0 h by chronic staest in serum and VLDL but not in chylomicrons. Postprandial sitostanol was increased by staest in VLDL only.


Chronic cholesterol absorption inhibition with large amount of plant stanol esters decreases plant sterols in triglyceride-rich lipoproteins. Acute plant stanol ester consumption increases sitostanol content in triglyceride-rich lipoproteins but suggests to decrease the risk of plant sterol and plant stanol accumulation into vascular wall by chylomicrons.


Plant stanol ester Postprandium Sitostanol Sitosterol Cholesterol synthesis Cholesterol absorption 



The expert technical assistance of Ms. Leena Kaipiainen, Arja Malkki, and Erja Kinnunen is greatly acknowledged. This work was supported by Raisio Group Plc [grant number CL2007_011].

Conflict of interest

The authors claim no conflicts of interest associated with the manuscript.


  1. 1.
    Gylling H, Miettinen TA (1994) Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia 37:773–780CrossRefGoogle Scholar
  2. 2.
    Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E (1995) Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med 333:1308–1312CrossRefGoogle Scholar
  3. 3.
    Gylling H, Rajaratnam R, Miettinen TA (1997) Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Circulation 96:4226–4231CrossRefGoogle Scholar
  4. 4.
    Gylling H, Puska P, Vartiainen E, Miettinen TA (1999) Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population. J Lipid Res 40:593–600Google Scholar
  5. 5.
    Miettinen TA, Vuoristo M, Nissinen M, Järvinen HJ, Gylling H (2000) Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine. Am J Clin Nutr 71:1095–1102Google Scholar
  6. 6.
    Gylling H, Hallikainen M, Nissinen MJ, Simonen P, Miettinen TA (2010) Very high plant stanol intake and serum plant stanols and non-cholesterol sterols. Eur J Nutr 49:111–117CrossRefGoogle Scholar
  7. 7.
    Relas H, Gylling H, Miettinen TA (2000) Effect of stanol ester on postabsorptive squalene and retinyl palmitate. Metabolism 49:473–478CrossRefGoogle Scholar
  8. 8.
    Relas H, Gylling H, Miettinen TA (2001) Acute effect of dietary stanyl ester dose on post-absorptive α-tocopherol, β-carotene, retinol and retinyl palmitate concentrations. Br J Nutr 85:141–147CrossRefGoogle Scholar
  9. 9.
    Gylling H, Hallikainen M, Nissinen MJ, Miettinen TA (2010) The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitamins. Clin Nutr 29:112–118CrossRefGoogle Scholar
  10. 10.
    Miettinen TA (1988) Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res 29:43–51Google Scholar
  11. 11.
    Miettinen TA, Tilvis RS, Kesäniemi YA (1990) Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol 131:20–31Google Scholar
  12. 12.
    Miettinen TA, Tilvis RS, Kesäniemi YA (1989) Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism 38:136–140CrossRefGoogle Scholar
  13. 13.
    Miettinen TA, Gylling H, Nissinen MJ (2011) The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr Metab Cardiovasc Dis. doi: 10.1016/j.numecd.2011.05.005
  14. 14.
    Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A (1994) Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106:83–97CrossRefGoogle Scholar
  15. 15.
    Zilversmit DB (1979) Atherogenesis: a postprandial Phenomenon. Circulation 60:473–485CrossRefGoogle Scholar
  16. 16.
    Miettinen TA (1982) Diurnal variation of cholesterol precursors squalene and methyl sterols in human plasma lipoproteins. J Lipid Res 23:466–473Google Scholar
  17. 17.
    Miettinen TA, Nissinen M, Lepäntalo M, Albäck A, Railo M, Vikatmaa P, Kaste M, Mustanoja S, Gylling H (2011) Non-cholesterol sterols in serum and endarterectomized carotid arteries after a short-term plant stanol and sterol ester challenge. Nutr Metab Cardiovasc Dis 21:182–188CrossRefGoogle Scholar
  18. 18.
    Katan MB, Grundy SM, Jones P, Law M, Miettinen T, Paoletti R (2003) Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78:965–978Google Scholar
  19. 19.
    Miettinen TA, Railo M, Lepäntalo M, Gylling H (2005) Plant sterols in serum and in atherosclerotic plaques of patients undergoing carotid endarterectomy. J Am Coll Cardiol 45:1792–1801CrossRefGoogle Scholar
  20. 20.
    Helske S, Miettinen TA, Gylling H, Mäyränpää M, Lommi J, Turto H, Werkkala K, Kupari M, Kovanen PT (2008) Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves. J Lipid Res 49:1511–1518CrossRefGoogle Scholar
  21. 21.
    Weingärtner O, Lütjohann D, Shengbo J, Weisshoff N, List F, Sudhop T, von Bergmann K, Gertz K, König J, Schäfers HJ, Endres M, Böhm M, Laufs U (2008) Vascular effects of diet supplementation with plant sterols. J Am Coll Cardiol 51:1553–1561CrossRefGoogle Scholar
  22. 22.
    Ketomäki A, Gylling H, Miettinen TA (2005) Non-cholesterol sterols in serum, lipoproteins, and red cells in statin-treated FH subjects off and on plant stanol and sterol ester spreads. Clin Chim Acta 353:75–86CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • H. Gylling
    • 1
    • 2
    Email author
  • M. Hallikainen
    • 2
  • P. Simonen
    • 1
  • H. E. Miettinen
    • 1
  • M. J. Nissinen
    • 3
  • T. A. Miettinen
    • 1
  1. 1.Department of Medicine, Division of Internal MedicineUniversity of HelsinkiHUS, HelsinkiFinland
  2. 2.Department of Clinical NutritionUniversity of Eastern FinlandKuopioFinland
  3. 3.Department of Medicine, Division of GastroenterologyUniversity of HelsinkiHUS, HelsinkiFinland

Personalised recommendations